PL1937274T3 - Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcją - Google Patents
Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcjąInfo
- Publication number
- PL1937274T3 PL1937274T3 PL06791828T PL06791828T PL1937274T3 PL 1937274 T3 PL1937274 T3 PL 1937274T3 PL 06791828 T PL06791828 T PL 06791828T PL 06791828 T PL06791828 T PL 06791828T PL 1937274 T3 PL1937274 T3 PL 1937274T3
- Authority
- PL
- Poland
- Prior art keywords
- estradiol valerate
- dienogest
- daily dose
- dose units
- oral
- Prior art date
Links
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 title abstract 7
- 229960004766 estradiol valerate Drugs 0.000 title abstract 7
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 title abstract 5
- 229960003309 dienogest Drugs 0.000 title abstract 5
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 title abstract 2
- 206010027514 Metrorrhagia Diseases 0.000 title abstract 2
- 229940127234 oral contraceptive Drugs 0.000 title abstract 2
- 239000003539 oral contraceptive agent Substances 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 229940068196 placebo Drugs 0.000 abstract 2
- 239000000902 placebo Substances 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 1
- 229940083544 estradiol 2 mg Drugs 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05022324A EP1787649B1 (de) | 2005-10-13 | 2005-10-13 | Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption |
| US72759205P | 2005-10-17 | 2005-10-17 | |
| EP06791828A EP1937274B1 (de) | 2005-10-13 | 2006-09-05 | Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption |
| PCT/EP2006/008626 WO2007042111A2 (de) | 2005-10-13 | 2006-09-05 | Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1937274T3 true PL1937274T3 (pl) | 2012-07-31 |
Family
ID=37678725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06791828T PL1937274T3 (pl) | 2005-10-13 | 2006-09-05 | Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcją |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1937274B1 (pl) |
| AT (1) | ATE546144T1 (pl) |
| CY (1) | CY1112775T1 (pl) |
| DK (1) | DK1937274T3 (pl) |
| ES (1) | ES2382459T3 (pl) |
| PL (1) | PL1937274T3 (pl) |
| PT (1) | PT1937274E (pl) |
| SI (1) | SI1937274T1 (pl) |
| WO (1) | WO2007042111A2 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201316144D0 (en) * | 2013-09-11 | 2013-10-23 | Crown Packaging Technology Inc | Universal seaming chuck |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
| DE19540253C2 (de) * | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene |
| US6251956B1 (en) | 1998-08-20 | 2001-06-26 | Ortho Pharmaceutical Corporation | Combination progestin oral contraceptive regimen |
| DE102004019743B4 (de) * | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
-
2006
- 2006-09-05 ES ES06791828T patent/ES2382459T3/es active Active
- 2006-09-05 DK DK06791828.4T patent/DK1937274T3/da active
- 2006-09-05 SI SI200631333T patent/SI1937274T1/sl unknown
- 2006-09-05 PT PT06791828T patent/PT1937274E/pt unknown
- 2006-09-05 PL PL06791828T patent/PL1937274T3/pl unknown
- 2006-09-05 AT AT06791828T patent/ATE546144T1/de active
- 2006-09-05 WO PCT/EP2006/008626 patent/WO2007042111A2/de not_active Ceased
- 2006-09-05 EP EP06791828A patent/EP1937274B1/de active Active
-
2012
- 2012-05-18 CY CY20121100460T patent/CY1112775T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007042111A3 (de) | 2007-10-11 |
| DK1937274T3 (da) | 2012-06-18 |
| CY1112775T1 (el) | 2016-02-10 |
| SI1937274T1 (sl) | 2012-06-29 |
| EP1937274B1 (de) | 2012-02-22 |
| PT1937274E (pt) | 2012-05-28 |
| ES2382459T3 (es) | 2012-06-08 |
| EP1937274A2 (de) | 2008-07-02 |
| WO2007042111A2 (de) | 2007-04-19 |
| ATE546144T1 (de) | 2012-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| HRP20070188B1 (hr) | Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva | |
| RU2009120528A (ru) | Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла | |
| JP2010508275A5 (pl) | ||
| JP2007535519A5 (pl) | ||
| AR048722A1 (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos | |
| NZ591627A (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
| HRP20090418T1 (hr) | Farmaceutski pripravak koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| MX2007013137A (es) | Regimen anticonceptivo con dosificacion de estrogeno ampliada. | |
| NO20072893L (no) | Fast, peroralt prevensjonsmiddel | |
| AR049197A1 (es) | Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| HRP20100513T4 (hr) | Višefazni kontracepcijski pripravak zasnovan na prirodnom estrogenu | |
| SI1937274T1 (sl) | Uporaba estradiolvalerata v kombinaciji z dienogestom za oralno terapijo disfunkcionalne maternične krvavitve skupaj z oralno kontracepcijo | |
| NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
| AR049196A1 (es) | Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona | |
| AR049195A1 (es) | Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento | |
| TH148141A (th) | การใช้เอสตราไดออลวาเลอเรตหรือเอสตราไดออลร่วมกับไดอีโนเจสต์สำหรับการรักษาโดยให้ทางปากในการตกเลือดในมดลูกแบบที่ทำงานผิดปกติ ร่วมกับยาคุมกำเนิดสำหรับให้ทางปาก |